Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.75
0.00 (0.00%)
At close: Apr 10, 2026, 4:00 PM EDT
5.69
-0.06 (-1.04%)
After-hours: Apr 10, 2026, 4:10 PM EDT

Champions Oncology Ratios and Metrics

Millions USD. Fiscal year is May - Apr.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21
80996667104144
Market Cap Growth
-39.65%49.41%-1.06%-35.83%-27.85%46.50%
Enterprise Value
77.7293.3669.463.91103.26148.03
Last Close Price
5.757.154.854.927.6810.73
PE Ratio
-21.67-8.98-12.62192.00536.50
Forward PE
-119.17--42.9577.31
PEG Ratio
----5.445.44
PS Ratio
1.381.731.311.242.113.51
PB Ratio
18.6426.12-34.6514.3711.4219.38
P/TBV Ratio
18.7627.04-34.5314.3711.9621.05
P/FCF Ratio
20.9214.08-9.4660.5825.25-29.01
P/OCF Ratio
18.1713.34-10.7416.7815.98-85.62
EV/Sales Ratio
1.341.641.381.192.103.61
EV/EBITDA Ratio
-15.07-12.64-21.2346.2295.50
EV/EBIT Ratio
-20.50-9.44-12.16170.11404.45
EV/FCF Ratio
20.3713.34-9.9558.1025.11-29.83
Debt / Equity Ratio
0.771.23-3.201.590.921.18
Debt / EBITDA Ratio
-1.860.99-1.35-2.864.246.19
Debt / FCF Ratio
-0.87-1.077.822.30-1.93
Net Debt / Equity Ratio
-0.52-0.98-2.53-0.330.050.66
Net Debt / EBITDA Ratio
0.85-0.59-0.880.510.213.17
Net Debt / FCF Ratio
--0.53-0.69-1.380.11-0.99
Asset Turnover
4.071.951.661.551.561.70
Quick Ratio
0.340.410.560.831.061.04
Current Ratio
0.980.940.630.901.131.13
Return on Equity (ROE)
-107.03%503.05%-532.46%-77.70%6.63%5.78%
Return on Assets (ROA)
-19.02%15.82%-24.23%-15.28%1.81%1.25%
Return on Invested Capital (ROIC)
-44.18%29.56%-45.57%-28.26%2.86%2.39%
Return on Capital Employed (ROCE)
-67.57%69.61%-85.69%-34.49%3.54%2.95%
Earnings Yield
-2.93%4.62%-11.13%-7.93%0.52%0.19%
FCF Yield
4.78%7.10%-10.58%1.65%3.96%-3.45%
Buyback Yield / Dilution
1.39%-5.31%-0.04%4.37%2.84%-23.05%
Total Shareholder Return
1.39%-5.31%-0.04%4.37%2.84%-23.05%
Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q